|
Market Closed -
NYSE
23:00:02 26/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 119.19 USD | +0.57% |
|
+0.39% | +48.71% |
| 10-20 | Haemonetics Gets FDA Approval for Vascular Closure Device | DJ |
| 10-20 | Haemonetics says FDA clears vascular closure device | RE |
| Market Cap | 5.42B 4.85B 4.49B 4.06B 7.6B 516B 7.73B 53.99B 21.35B 270B 20.35B 19.92B 854B | P/E 2027 * |
30.1x | P/E 2028 * | 26.4x |
|---|---|---|---|---|---|
| Enterprise Value | 6.08B 5.44B 5.03B 4.56B 8.53B 579B 8.67B 60.58B 23.96B 303B 22.84B 22.35B 959B | EV / Sales 2027 * |
4.29x | EV / Sales 2028 * | 3.85x |
| Free-Float |
98.74% | Yield 2027 * |
0.84% | Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| HAE | Delayed | |
CBOE
| HAE | Real-time | |
|
Tradegate
| HAZ | Real-time | |
|
Deutsche Boerse AG
| HAZ | Delayed | |
|
Börse Stuttgart
| HAZ | Delayed | |
|
Boerse Muenchen
| HAZ | Real-time |
Last Transcript: Haemonetics Corporation
| 1 day | +0.57% | ||
| 1 week | +0.39% | ||
| Current month | +13.19% | ||
| 1 month | +13.19% | ||
| 3 months | +51.29% | ||
| 6 months | +98.88% | ||
| Current year | +48.71% |
| 1 week | 115.49 |  | 119.43 |
| 1 month | 101.32 | | 123.77 |
| Current year | 51 | | 123.77 |
| 1 year | 48.98 | | 123.77 |
| 3 years | 47.32 | | 123.77 |
| 5 years | 43.5 | | 123.77 |
| 10 years | 32.76 | | 142.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 16/05/2016 | |
James D'Arecca
DFI | Director of Finance/CFO | 55 | 11/04/2022 |
Frank Chan
COO | Chief Operating Officer | 56 | 01/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Kroll
BRD | Director/Board Member | 73 | 01/01/2006 |
| Director/Board Member | 62 | 16/05/2016 | |
Robert Abernathy
BRD | Director/Board Member | 71 | 18/10/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/24/26 A | Free | Director | 2,538 | 0.0056% | ||
| 7/24/26 A | Free | Director | 2,538 | 0.0056% | ||
| 7/24/26 A | Free | Director | 2,538 | 0.0056% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.57% | +0.39% | +132.52% | +42.66% | 5.42B | |
| +1.14% | +0.79% | -17.32% | +11.60% | 181B | |
| -0.33% | +2.75% | -19.82% | +18.39% | 117B | |
| -0.65% | +2.18% | +1.20% | +34.70% | 116B | |
| +1.63% | +18.01% | -43.89% | +5.70% | 89.94B | |
| -0.30% | -2.94% | -0.81% | +74.97% | 62.97B | |
| +1.00% | +1.46% | +8.32% | +81.92% | 55.43B | |
| -1.27% | +2.96% | +5.68% | -22.74% | 53.49B | |
| +1.75% | +2.59% | -11.02% | +43.47% | 44.92B | |
| -0.10% | +3.84% | -4.30% | -8.30% | 33.87B | |
| Average | +0.33% | +3.21% | +5.06% | +28.24% | 76.1B | |
| Weighted average by Cap. | +0.36% | +3.28% | -11.15% | +24.64% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 1.42B 1.27B 1.17B 1.06B 1.99B 135B 2.02B 14.11B 5.58B 70.51B 5.32B 5.2B 223B | 1.5B 1.34B 1.24B 1.12B 2.1B 142B 2.13B 14.89B 5.89B 74.41B 5.61B 5.49B 236B |
| Net income | 177M 159M 147M 133M 249M 16.88B 253M 1.77B 699M 8.83B 666M 652M 27.95B | 207M 185M 171M 155M 291M 19.72B 295M 2.06B 816M 10.31B 778M 761M 32.65B |
| Net Debt | 662M 592M 548M 496M 928M 62.98B 943M 6.59B 2.61B 32.94B 2.48B 2.43B 104B | 327M 293M 271M 245M 459M 31.12B 466M 3.26B 1.29B 16.28B 1.23B 1.2B 51.54B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/10/26 | $119.19 | +0.57% | 469,737 |
| 23/10/26 | $118.51 | +2.02% | 777,377 |
| 22/10/26 | $116.16 | -0.81% | 365,125 |
| 21/10/26 | $117.11 | -0.93% | 843,472 |
| 20/10/26 | $118.21 | -0.44% | 585,002 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HAE Stock
Select your edition
All financial news and data tailored to specific country editions
